These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27000702)

  • 1. Increased resistin levels in the serum and cerebrospinal fluid of patients with neuromyelitis optica.
    Qi Y; Jia K; Zhang DQ; Li T; Li LM; Zhang LJ; Wang J; Gao CL; Sun LS; Shi FD; Yang L
    Clin Chim Acta; 2016 May; 456():176-179. PubMed ID: 27000702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
    Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
    Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
    Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between neuromyelitis optica-IgG status and spinal cord magnetic resonance imaging in patients with neuromyelitis optica.
    Zhong XN; Wang HH; Bao J; Li R; Long YM; Lu ZQ; Dai YQ; Qiu W; Hu XQ
    Chin Med J (Engl); 2012 Jan; 125(2):270-4. PubMed ID: 22340558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack.
    Cha E; Lee KM; Park KD; Park KS; Lee KW; Kim SM; Lee J
    PLoS One; 2016; 11(12):e0167819. PubMed ID: 27942009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased soluble C5b-9 in CSF of neuromyelitis optica.
    Wang H; Wang K; Wang C; Qiu W; Lu Z; Hu X
    Scand J Immunol; 2014 Feb; 79(2):127-30. PubMed ID: 24313854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica.
    Uzawa A; Mori M; Masuda S; Muto M; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):517-22. PubMed ID: 23255728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum uric acid levels and their correlation with clinical and cerebrospinal fluid parameters in patients with neuromyelitis optica.
    Liu C; Xu Y; Cui L; Wang J; Peng B; Zhong L; Chen X
    J Clin Neurosci; 2013 Feb; 20(2):278-80. PubMed ID: 23164828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica.
    Uzawa A; Mori M; Masuda H; Ohtani R; Uchida T; Sawai S; Kuwabara S
    Clin Chim Acta; 2017 Jun; 469():144-149. PubMed ID: 28283439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
    Takano R; Misu T; Takahashi T; Sato S; Fujihara K; Itoyama Y
    Neurology; 2010 Jul; 75(3):208-16. PubMed ID: 20644148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
    Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
    Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
    Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
    Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
    Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and cerebrospinal fluid concentrations of homoarginine, arginine, asymmetric and symmetric dimethylarginine, nitrite and nitrate in patients with multiple sclerosis and neuromyelitis optica.
    Haghikia A; Kayacelebi AA; Beckmann B; Hanff E; Gold R; Haghikia A; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1837-45. PubMed ID: 26055922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
    Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
    Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
    Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloride imbalance between serum and CSF in the acute phase of neuromyelitis optica.
    Akaishi T; Takahashi T; Nakashima I
    J Neuroimmunol; 2018 Feb; 315():45-49. PubMed ID: 29306405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
    de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
    Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.